Comparison of two molecular methods for diagnosis of Chlamydia trachomatis

Autores: Molicotti Paola, Usai Donatella, Cubeddu Marina, Sechi Leonardo Antonio, Zanetti Stefania

Fragmento

Introduction Chlamydia trachomatis is an obligate intracellular microorganism responsible for several diseases. It is considered the most common bacterial sexually transmitted infection (STI) worldwide. The World Health Organization (WHO) estimates that 92 million new cases of C. trachomatis occur globally every year. An estimated 3 to 4 million new cases are diagnosed every year in the United States, 5 million in Western Europe, and 16 million in sub-Saharan Africa. According to estimates fron the Centers for Disease Control and Prevention (CDC), 75% of new cases in the United States are diagnosed in asymptomatic women. The sequelae of chlamydial infection in women are severe and can lead to serious complications, including pelvic inflammatory disease, ectopic pregnancy, infertility, and chronic pelvic pain. Chlamydial genital infections have also been reported to increase human immunodeficiency virus transmission and influence the development of human papillomavirus-induced adenocarcinoma. In addition, pregnant women infected with C. trachomatis put their children at risk for conjunctivitis and pneumonitis through mother-to-child transmission. In men C. trachomatis is associated with non-gonococcal urethritis and epididymitis. In the male high-risk group, 50% are asymptomatic with mild symptoms.

Palabras clave:

2013-01-17   |   464 visitas   |   Evalua este artículo 0 valoraciones

Vol. 7 Núm.1. Enero 2013 Pags. 64-66 J Infect Developing Countries 2013; 7(1)